Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes

Renal denervation is a promising therapy for patients with refractory hypertension, backed by a growing body of clinical evidence and renewed clinical interest. In this video, interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation at ISET 2026, “Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes”. Dr. Misra reviews appropriate patient selection, examines the latest clinical trial data, and discusses real-world outcomes, offering a look at where renal denervation stands in today’s treatment landscape.